GLP-1 Collective

Policy Tracker · Patient Lens · July 20, 2026

Moberly joins a growing line of towns suing Novo Nordisk over Ozempic prices

A Missouri city says list prices, not just patients, are footing the bill for GLP-1 drugs.

4 developments affecting GLP-1 access were tracked on Sunday, July 19, 2026, across 1 category. Each entry links to the full record.

## Courts and enforcement

**[Moberly sues Novo Nordisk over GLP-1 drugs](/lawsuits/cl-73640001)**.

**[Lawsuit claims Novo Nordisk misled patients on drug prices](/lawsuits/cl-73639535)**.

**[Patient sues Novo Nordisk over GLP-1 pricing and marketing](/lawsuits/cl-73643247)**.

**[Patient sues Novo Nordisk over GLP-1 pricing and marketing](/lawsuits/cl-73642197)**.

By Amanda Bonello

Originally published by Patient Lens on GLP-1 Laws, operated by GLP-1 Studio LLC — a for-profit company founded by the Collective's Executive Director. Republished here in full, with permission, at no cost. The Collective pays nothing for it and receives no payment for publishing it. How this works.